Interferon-Gamma–Producing CD8+ Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor–Colitis
Sasson SC. et al, (2021), Gastroenterology, 161, 1229 - 1244.e9
Immunotherapy-related hepatitis: real-world experience from a tertiary centre
Cheung V. et al, (2019), Frontline Gastroenterology, 10, 364 - 371
Real-time data monitoring for ulcerative colitis: patient perception and qualitative analysis
Walsh A. et al, (2019), Intestinal Research, 17, 365 - 374
Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective Analysis
Walsh A. et al, (2019), Journal of Crohn's and Colitis, 13, 424 - 430
Real-world data: the incidence, diagnosis, and management outcomes of patients with immunotherapy-related colitis in two tertiary centres
Cheung V. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S137 - S138
Can patients enter the 'Standard Set' ICHOM parameters by completing electronic questionnaires?
Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S140 - S141
Could an escalation of therapy or intervention (ETI) calculator be used to triage appointments for patients with ulcerative colitis?
Walsh A. et al, (2019), JOURNAL OF CROHNS & COLITIS, 13, S397 - S398
INCIDENCE AND MANAGEMENT OF IMMUNOTHERAPY-INDUCED COLITIS IN A TERTIARY IBD CENTRE - CLINICAL PRACTICE DATA
Gupta T. et al, (2018), GUT, 67, A186 - A187
DEVELOPING AN INDEX THAT PREDICTS ESCALATION OF THERAPY AT AN OUTPATIENT APPOINTMENT IN PATIENTS WITH KNOWN ULCERATIVE COLITIS (UC)
Walsh A. et al, (2018), GASTROENTEROLOGY, 154, S587 - S587
NEW FAECAL CALPROTECTIN CUT-OFF POINTS FOR REMISSION AND ACTIVE DISEASE DEFINED BY UCEIS AND NANCY INDICES IN ULCERATIVE COLITIS
Walsh A. et al, (2018), GASTROENTEROLOGY, 154, S187 - S187
Fertility and reproduction in a tertiary IBD centre: the Oxford experience
Lee LH. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S173 - S173
Incidence and management of immunotherapy-induced colitis in a tertiary melanoma and IBD centre: Clinical practice data
Cheung V. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S198 - S198
The impact of a virtual clinic on clinical decision-making and healthcare resource use vs. standard care: The Oxford experience
FitzPatrick M. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S393 - S394
TrueColours ulcerative colitis (TCUC): Will patients with UC complete digital questionnaires in real-time?
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S286 - S286
Can daily SCCAI measurements over a 6-month period better phenotype the pattern of disease in ulcerative colitis?
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S359 - S360
Development of an index that predicts escalation of therapy at an outpatient appointment in patients with known ulcerative colitis (UC)
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S321 - S321
New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S233 - S233
Should extraintestinal manifestations (EIMs) be part of disease activity assessment in ulcerative colitis?
Walsh A. et al, (2018), JOURNAL OF CROHNS & COLITIS, 12, S461 - S461